Antitachycardia pacing and low-energy cardioversion for ventricular tachycardia termination: a clinical perspective.
Estes NA 3rd, Haugh CJ, Wang PJ, Manolis AS.
Am Heart J. 1994 Apr;127(4 Pt 2):1038-46. doi: 10.1016/0002-8703(94)90084-1.
PMID:8160578
Incidence of Ventricular Arrhythmias and 1-Year Predictors of Mortality in Patients Treated With Implantable Cardioverter-Defibrillator Undergoing Generator Replacement.
Demarchi A, Cornara S, Sanzo A, Savastano S, Petracci B, Vicentini A, Pontillo L, Baldi E, Frigerio L, Astuti M, Leonardi S, Ghio S, Oltrona Visconti L, Rordorf R.
J Am Heart Assoc. 2021 Feb 16;10(4):e018090. doi: 10.1161/JAHA.120.018090. Epub 2021 Jan 30.
PMID:33522246
Reuse of pacemakers and implantable cardioverter-defibrillators: systematic review, meta-analysis and quality assessment of the body of evidence.
Psaltikidis EM, Costa EAM, Graziano KU.
Expert Rev Med Devices. 2021 Jun;18(6):553-567. doi: 10.1080/17434440.2021.1927706. Epub 2021 Jun 17.
PMID:33969787
Assessment on Implantable Defibrillators and the Evidence for Primary Prevention of Sudden Cardiac Death [Internet].
Uhlig K, Balk EM, Earley A, Persson R, Garlitski AC, Chen M, Lamont JL, Miligkos M, Avendano EE.
Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jun 26.